Monitoring Immune Responses in Neuroblastoma Patients during Therapy

Neuroblastoma (NBL) is the most common extracranial solid tumor in childhood. Despite intense treatment, children with this high-risk disease have a poor prognosis. Immunotherapy showed a significant improvement in event-free survival in high-risk NBL patients receiving chimeric anti-GD2 in combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Szanto, Celina L., Cornel, Annelisa M., Vijver, Saskia V., Nierkens, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072382/
https://www.ncbi.nlm.nih.gov/pubmed/32102342
http://dx.doi.org/10.3390/cancers12020519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072382/
https://www.ncbi.nlm.nih.gov/pubmed/32102342
http://dx.doi.org/10.3390/cancers12020519

Ejemplares similares